Margaret Farrelly

Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma

Peter Hersey, Scott W. Menzies, Gary M. Halliday et al. · Cancer Immunology Immunotherapy · 2004 · 118 citations · Full text

Tumor Immunology, Disseminated Melanoma, Cancer Immunosurveillance +8

LncRNA REG1CP promotes tumorigenesis through an enhancer complex to recruit FANCJ helicase for REG3A transcription

Hamed Yari, Lei Jin, Teng Liu et al. · Nature Communications · 2019 · 68 citations · Full text

INPP4B is an oncogenic regulator in human colon cancer

Shanchun Guo, M N, Rui Yang et al. · Oncogene · 2015 · 65 citations · Full text

Pathology, 4-Phosphatase Type Ii, Tumor Biology +16

Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma

Peter Hersey, Scott W. Menzies, Brendon J. Coventry et al. · Cancer Immunology Immunotherapy · 2004 · 52 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Autoimmune Disease +13

Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3

Fritz Lai, Su Guo, Lei Jin et al. · Cell Death and Disease · 2013 · 50 citations · Full text